Literature DB >> 11838858

Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue.

Michael P Scola1, Susan D Thompson, Hermine I Brunner, Monica K Tsoras, David Witte, Marc A Van Dijk, Alexei A Grom, Murray H Passo, David N Glass.   

Abstract

OBJECTIVE: To compare synovial tissue cytokine mRNA expression between patients with juvenile rheumatoid arthritis (JRA) and a heterogeneous group of non-autoimmune arthropathies (controls) with respect to type 1/type 2 balance.
METHODS: Thirty-five JRA (average 9.1 years' disease duration) and 13 control synovial tissues were studied. As a measure of the type 1/type 2 cytokine balance in a subset of the JRA and control tissues, interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) mRNA levels were measured by competitive fragment reverse transcription-polymerase chain reaction. To quantitate additional cytokines relevant to this balance, multiprobe ribonuclease protection assays were employed measuring IL-5, IL-10, IL-13, IL-15, IL-18, and IL-12 (p35 and p40 subunits). Immunohistochemistry was performed on JRA tissues using antibodies specific for IL-15 and IL-18.
RESULTS: A higher IFN-gamma:IL-4 ratio (p = 0.034) was found in JRA tissues compared to controls. JRA tissues also displayed higher mRNA levels of IL-12p35 (p = 0.021), IL-15 (p = 0.002), and IL-18 (p = 0.017), but not IL-4 and IL-10. IFN-gamma expression in JRA, but not controls, correlated strongly with IL-12p35 (r = 0.63) and IL-12p40 (r = 0.73) levels. A subset of IL-15+ and IL-18+ cells was detected in JRA synovial tissues, largely within perivascular aggregates.
CONCLUSION: JRA synovial tissue cytokine expression patterns indicate a type 1 bias, even in the later stages of disease. The strong correlation between IFN-gamma and IL-12 in JRA suggests a prominent role for IL-12 in promoting the type I bias, while IL-15 and IL-18 may also indirectly increase IFN-gamma expression and further bias the immune response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11838858

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

Review 1.  New strategies to control inflammatory synovitis: interleukin 15 and beyond.

Authors:  I B McInnes; J A Gracie; M Harnett; W Harnett; F Y Liew
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques.

Authors:  Ligong Chen; Jarad M Schiffer; Shannon Dalton; Carol L Sabourin; Nancy A Niemuth; Brian D Plikaytis; Conrad P Quinn
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

3.  Localized Sympathectomy Reduces Mechanical Hypersensitivity by Restoring Normal Immune Homeostasis in Rat Models of Inflammatory Pain.

Authors:  Wenrui Xie; Sisi Chen; Judith A Strong; Ai-Ling Li; Ian P Lewkowich; Jun-Ming Zhang
Journal:  J Neurosci       Date:  2016-08-17       Impact factor: 6.167

4.  Cytokines and juvenile idiopathic arthritis.

Authors:  Patricia Woo
Journal:  Curr Rheumatol Rep       Date:  2002-12       Impact factor: 4.592

5.  The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial.

Authors:  Sudha Visvanathan; Carrie Wagner; Joseph C Marini; Daniel J Lovell; Alberto Martini; Ross Petty; Ruben Cuttica; Patricia Woo; Graciela Espada; Marco Gattorno; Maria T Apaz; Eileen Baildam; Anders Fasth; Valeria Gerloni; Pekka Lahdenne; Pierre Quartier; Rotraud Saurenmann; Suzanne Travers; Alan Mendelsohn; Stephen Xu; Edward H Giannini; Nicolino Ruperto
Journal:  Pediatr Rheumatol Online J       Date:  2010-09-07       Impact factor: 3.054

6.  Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis.

Authors:  Jeffrey H Ruth; Christy C Park; M Asif Amin; Charles Lesch; Hubert Marotte; Shiva Shahrara; Alisa E Koch
Journal:  Arthritis Res Ther       Date:  2010-06-16       Impact factor: 5.156

7.  Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.

Authors:  Marija Jelusić; Ivan Kresimir Lukić; Lana Tambić-Bukovac; Klara Dubravcić; Ivan Malcić; Igor Rudan; Drago Batinić
Journal:  Clin Rheumatol       Date:  2006-11-25       Impact factor: 2.980

8.  Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.

Authors:  D Y Chen; J L Lan; F J Lin; T Y Hsieh; M C Wen
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

9.  Murine T cell lines can change CD25 expression patterns as well as proliferation and cell death patterns in response to interleukin 2.

Authors:  Hiroshi Kano; Akio Ametani; Mamoru Totsuka; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

10.  Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13.

Authors:  Susan D Thompson; Miranda C Marion; Marc Sudman; Mary Ryan; Monica Tsoras; Timothy D Howard; Michael G Barnes; Paula S Ramos; Wendy Thomson; Anne Hinks; Johannes-Peter Haas; Sampath Prahalad; John F Bohnsack; Carol A Wise; Marilynn Punaro; Carlos D Rosé; Nicholas M Pajewski; Michael Spigarelli; Mehdi Keddache; Michael Wagner; Carl D Langefeld; David N Glass
Journal:  Arthritis Rheum       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.